| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 41 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $44.33 | $1,756,871.44 | -0.6% | |
| Aug 13, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $45.44 | $1,801,070.30 | -0.4% | |
| Aug 5, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $45.22 | $271,320.00 | -17.4% | |
| Jul 25, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $46.74 | $1,852,702.66 | -0.5% | |
| Jul 11, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $44.97 | $505,868.00 | -1.8% | |
| Jul 11, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $44.97 | $1,782,613.73 | -0.4% | |
| Jul 8, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $42.60 | $255,570.00 | -9.3% | |
| Jun 28, 2019 | Kouchakji Elias | SVP, Clinical Dev, Drug Safety | Sell | 2,873 | $45.00 | $129,285.00 | -2.6% | |
| Jun 20, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $44.20 | $1,752,005.96 | -0.5% | |
| Jun 19, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $44.05 | $495,562.50 | -3.6% |